Holdings
Omega Fund Management, LLC
As of Sep 30, 2026, Omega Fund Management, LLC reported 10 positions worth US$125M. Largest: Nuvation Bio Inc., Bicara Therapeutics Inc. and Beta Bionics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Nuvation Bio Inc. | 7.15M | US$40M | −930K | Sep 30, 2026 |
| Bicara Therapeutics Inc. | 1.76M | US$32.8M | −62,238 | Sep 30, 2026 |
| Beta Bionics, Inc. | 962K | US$18.3M | −354K | Sep 30, 2026 |
| BridgeBio Oncology Therapeutics, Inc. | 3.29M | US$13.5M | no change | Sep 30, 2026 |
| Kestra Medical Technologies, Ltd. | 362K | US$10.3M | −660K | Sep 30, 2026 |
| Immunic, Inc. | 430K | US$4M | new | Sep 30, 2026 |
| Sana Biotechnology, Inc. | 844K | US$2.46M | no change | Sep 30, 2026 |
| ImageneBio, Inc. | 455K | US$2.09M | no change | Sep 30, 2026 |
| enGene Holdings Inc. | 876K | US$1.75M | no change | Sep 30, 2026 |
| Odyssey Therapeutics, Inc. | 2,893 | US$64,282 | no change | Sep 30, 2026 |